Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Biscione, G. Crigna, F. Pasqua, M. Cazzola (Velletri, Rome, Rome, Italy). Prulifloxacin in the treatment of acute exacerbations of COPD (AECOPD) in cigarette smokers. Eur Respir J 2008; 32: Suppl. 52, 2752

Member's Comments

No comment yet.

Related content which might interest you: Association of COPD inhaled  medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – COPD management Year: 2017 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Smoking and COPD exacerbations Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD) Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Antibiotics in acute exacerbation of asthma and COPD Source: Eur Respir Monogr 2017; 75: 150-158 Year: 2017 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 N-acetylcysteine for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Chronic bronchitis affects mortality in smokers with and without COPD Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Polypharmacy in patients with acute exacerbation of COPD Source: Annual Congress 2011 - COPD management Year: 2011 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007